Diabetes Device

Recommendations for first-line therapy and comorbidities, diabetes screening in adults and gestational diabetes testing are among the changes in the American Diabetes Association’s 2022 Standards of Care.

Universal funding of continuous glucose monitoring for children and adolescents in Australia led to rapid device uptake and continued use for most, as well as sustained improvements in HbA1c and other glycemic measures, registry data show.

The Healio and Endocrine Today editors have compiled the most read Diabetes in Real Life columns of 2021.

This year marked the 100th anniversary of insulin’s discovery in 1921, and professional societies and stakeholders have highlighted advances in formulations and delivery. Yet today, global insulin access and affordability issues persist.

CMS will expand Medicare coverage for all types of continuous glucose monitors, including adjunctive and non-adjunctive CGMs.

White Medicare beneficiaries were more likely to use an insulin pump or continuous glucose monitor than Black beneficiaries from 2017 to 2019, with the gap increasing over the 3-year period, according to study data.

Health care providers should facilitate and support people with diabetes who choose to use a do-it-yourself automated insulin delivery system, working together with patients to set “realistic” goals and minimize any hypoglycemia risk.

A group of diabetes researchers, providers, government officials and representatives from device manufacturers and patient organizations are aiming to make the diabetes device industry more environmentally sustainable.

Medtronic expanded a recall of remote controllers used with MiniMed 508 insulin pump or the MiniMed Paradigm family of insulin pumps due to potential cybersecurity risks, according to an FDA press release.

During my recent visit to Jordan, my brother’s family showed me some of the belongings of our late father. What caught my eyes was his old glucose meter (Figures). The device may be 15 years old.